Richard J. Ablin

Corporate Officer/Principal chez Tetragenex Pharmaceuticals, Inc.

Consumer Services

Health Technology

Postes actifs de Richard J. Ablin

Sociétés	Poste	Début	Fin
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Corporate Officer/Principal	05/02/2010	-

Sociétés	Poste	Début	Fin
The State University of New York	Directeur/Membre du Conseil	01/01/1989	01/01/1989
The State University of New York	Corporate Officer/Principal	01/01/1989	01/01/1989

State University of New York at Buffalo

Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	2
Director/Board Member	1
Doctorate Degree	1

Sectorielle

Consumer Services	3
Health Technology	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology

Entreprise privées

Health Technology